These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 9537408)

  • 1. Have you used an adeno vector...lately?
    Bernstein A
    Nat Genet; 1998 Apr; 18(4):305-6. PubMed ID: 9537408
    [No Abstract]   [Full Text] [Related]  

  • 2. Promoters and serotypes: targeting of adeno-associated virus vectors for gene transfer in the rat central nervous system in vitro and in vivo.
    Shevtsova Z; Malik JM; Michel U; Bähr M; Kügler S
    Exp Physiol; 2005 Jan; 90(1):53-9. PubMed ID: 15542619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human gene targeting by viral vectors.
    Russell DW; Hirata RK
    Nat Genet; 1998 Apr; 18(4):325-30. PubMed ID: 9537413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Site-specific integration of functional transgenes into the human genome by adeno/AAV hybrid vectors.
    Recchia A; Perani L; Sartori D; Olgiati C; Mavilio F
    Mol Ther; 2004 Oct; 10(4):660-70. PubMed ID: 15451450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AAV vectors: is clinical success on the horizon?
    Monahan PE; Samulski RJ
    Gene Ther; 2000 Jan; 7(1):24-30. PubMed ID: 10680012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Directed evolution of adeno-associated virus yields enhanced gene delivery vectors.
    Maheshri N; Koerber JT; Kaspar BK; Schaffer DV
    Nat Biotechnol; 2006 Feb; 24(2):198-204. PubMed ID: 16429148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted retrograde gene delivery into the injured cervical spinal cord using recombinant adenovirus vector.
    Nakajima H; Uchida K; Kobayashi S; Kokubo Y; Yayama T; Sato R; Baba H
    Neurosci Lett; 2005 Sep; 385(1):30-5. PubMed ID: 15936879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of gene targeting and gene transfer by adenoviral vectors in the analysis of neurotrophin-mediated neuronal plasticity.
    Griesbeck O; Korte M; Staiger V; Gravel C; Carroll P; Bonhoeffer T; Thoenen H
    Cold Spring Harb Symp Quant Biol; 1996; 61():77-83. PubMed ID: 9246437
    [No Abstract]   [Full Text] [Related]  

  • 9. Targeting specific neuronal populations using adeno- and lentiviral vectors: applications for imaging and studies of cell function.
    Teschemacher AG; Wang S; Lonergan T; Duale H; Waki H; Paton JF; Kasparov S
    Exp Physiol; 2005 Jan; 90(1):61-9. PubMed ID: 15542618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 'Autoreplication' of the vector genome in recombinant adenoviral vectors with different E1 region deletions and transgenes.
    Marienfeld U; Haack A; Thalheimer P; Schneider-Rasp S; Brackmann HH; Poller W
    Gene Ther; 1999 Jun; 6(6):1101-13. PubMed ID: 10455413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient gene transfer into human cord blood CD34+ cells and the CD34+CD38- subset using highly purified recombinant adeno-associated viral vector preparations that are free of helper virus and wild-type AAV.
    Nathwani AC; Hanawa H; Vandergriff J; Kelly P; Vanin EF; Nienhuis AW
    Gene Ther; 2000 Feb; 7(3):183-95. PubMed ID: 10694794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-selective viral gene delivery vectors for the vasculature.
    Baker AH; Kritz A; Work LM; Nicklin SA
    Exp Physiol; 2005 Jan; 90(1):27-31. PubMed ID: 15542621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current development of adeno-associated viral vectors.
    Romano G
    Drug News Perspect; 2005 Jun; 18(5):311-6. PubMed ID: 16193103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation and selection of targeted adenoviruses embodying optimized vector properties.
    Noureddini SC; Krendelshchikov A; Simonenko V; Hedley SJ; Douglas JT; Curiel DT; Korokhov N
    Virus Res; 2006 Mar; 116(1-2):185-95. PubMed ID: 16293334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral vectors for gene delivery in tissue engineering.
    Zhang X; Godbey WT
    Adv Drug Deliv Rev; 2006 Jul; 58(4):515-34. PubMed ID: 16762441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo.
    Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K
    J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safe gene vectors made simpler.
    Morsy MA; Caskey CT
    Nat Biotechnol; 1997 Jan; 15(1):17. PubMed ID: 9035097
    [No Abstract]   [Full Text] [Related]  

  • 18. Improved adeno-associated virus vector production with transfection of a single helper adenovirus gene, E4orf6.
    Allen JM; Halbert CL; Miller AD
    Mol Ther; 2000 Jan; 1(1):88-95. PubMed ID: 10933916
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adeno-cosmid cloning vectors for regulated gene expression.
    Giampaoli S; Nicolaus G; Delmastro P; Cortese R
    J Gene Med; 2002; 4(5):490-7. PubMed ID: 12221642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenovirus vector-mediated gene transfer into stem cells.
    Kawabata K; Sakurai F; Koizumi N; Hayakawa T; Mizuguchi H
    Mol Pharm; 2006; 3(2):95-103. PubMed ID: 16579638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.